Gastric cancer ranks as the fifth most common malignant tumor worldwide and is the third most common cause of cancer-related death. For advanced gastric cancer (AGC), neoadjuvant chemotherapy (NAC) can reduce its stage, increase the rate of radical resection, improve response to treatment, reduce the risk of local recurrence and improve survival rate. Regional arterial infusion chemotherapy (RAIC) is a form of NAC that involves directly injecting chemotherapeutic drugs into the tumor site through the tumor-feeding artery. RAIC increases the local drug concentration around the tumor, thereby improving the therapeutic responses and reducing the adverse effects of the drugs. In recent years, RAIC has attracted increasing attention. This article summarizes the basic principles, procedure, chemotherapy regimens, adverse drug reactions and complications, clinical applications and response evaluation of RAIC in the treatment of AGC.
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. https://doi.org/10.1002/ijc.29210
Mesenas, S., Vu, C., McStay, M., Forshaw, M., Doig, L., Mason, R., Boyle, N. and Meenan, J. (2008) A Large Series, Resection Controlled Study to Assess the Value of Radial EUS in Restaging Gastroesophageal Cancer Following Neoadjuvant Chemotherapy. Diseases of the Esophagus, 21, 37-42. https://doi.org/10.1111/j.1442-2050.2007.00731.x
He, Q., Li, Y., Ma, L., Ji, X. and Li, G. (2016) Application of FLEEOX Preoperative Chemotherapy via Intra-Arterial and Intravenous Administration in Treatment of Unresectable Locally Advanced Gastric Cancer. Journal of Gastrointestinal Surgery, 20, 1421-1427. https://doi.org/10.1007/s11605-016-3153-8
Li, G.L., Liu, K., Bao, Y., Cao, J.M., Xu, J., Wang, X.L., Wu, B. and Li, J.S. (2012) Retrospective Analysis of 56 Patients with Advanced Gastric Cancer Treated with Combination of Intravenous and Intra-Arterial Intensified Neoadjuvant Chemotherapy. Chinese Medical Journal (English), 125, 780-785.
Li, M., Zhang, J., Wang, D., Zhong, B., Tucker, S., Lu, C., Cheng, J., Cao, C., Xu, J., Xu, J. and Pan, H. (2009) A Phase II Study of Intra-Arterial Chemotherapy of 5-Fluorouracil, Cisplatin, and Mitomycin C for Advanced Nonresectable Gastric Cancer. Anti-Cancer Drugs, 20, 941-945. https://doi.org/10.1097/CAD.0b013e328331af3a
Li, Z.W. and Wang, L. (2013) Progression of Preoperative Regional Arterial Infusion Chemotherapy in Advanced Gastric Cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 16, 197-200.
Wu, Z.F., Cao, Q.H., Wu, X.Y., Chen, C., Xu, Z., Li, W.S., Yao, X.Q. and Liu, F.K. (2015) Regional Arterial Infusion Chemotherapy improves the Pathological Response Rate for Advanced Gastric Cancer with Short-Term Neoadjuvant Chemotherapy. Scientific Reports, 5, 17516. https://doi.org/10.1038/srep17516
Polysalov, V.N., Veriasova, N.N., Dolgikh, S.D. and Gapbarov, A. (2012) Regional Chemotherapy in Locally Advanced and Metastatic Gastric Cancer. Voprosy Onkologii, 58, 762-767.
Iida, T., Hirata, N., Hirakawa, M. and Noguchi, T. (2003) Preoperative Intraarterial Infusion Chemotherapy for Advanced Gastric Cancer—A Retrospective Review of Four Cases. Radiation Medicine, 21, 172-177.
Wu, Z., Zhu, W., Cao, Q., Chen, Z., Wu, X., Chen, C., Xu, Z., Li, W., Yao, X. and Liu, F. (2014) Application of Regional Arterial Infusion Chemotherapy in Short-Term Neoadjuvant Chemotherapy for Advanced Gastric Cancer. Zhonghua Wei Chang Wai Ke Za Zhi, 17, 1092-1095.
Inoue, Y. and Kusunoki, M. (2014) Advances and Directions in Chemotherapy using Implantable Port Systems for Colorectal Cancer: A Historical Review. Surgery Today, 44, 1406-1414. https://doi.org/10.1007/s00595-013-0672-8
Higashi, S., Kato, C., Sakumoto, H., Sumiyoshi, K., Takahahsi, T., Matsumoto, K., Kane, T., Sakoda, M., Takahashi, M., Hosono, Y., Asano, M. and Yamamoto, A. (1999) Arterial Infusion Therapy with Implantable Port for Inoperable Hepatobiliary Tumors. Japanese Journal of Cancer and Chemotherapy, 26, 1764-1767.
Van Cutsem, E., Moiseyenko, V.M., Tjulandin, S., Majlis, A., Constenla, M., Boni, C., Rodrigues, A., Fodor, M., Chao, Y., Voznyi, E., Risse, M.L. and Ajani, J.A. (2006) Phase III Study of Docetaxel and Cisplatin plus Fluorouracil Compared with Cisplatin and Fluorouracil as First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group. Journal of Clinical Oncology, 24, 4991-4997. https://doi.org/10.1200/JCO.2006.06.8429
Kang, Y.K., Kang, W.K., Shin, D.B., Chen, J., Xiong, J., Wang, J., Lichinitser, M., Guan, Z., Khasanov, R., Zheng, L., Philco-Salas, M., Suarez, T., Santamaria, J., Forster, G. and McCloud, P.I. (2009) Capecitabine/Cisplatin versus 5-fluorouracil/cisplatin as First-Line Therapy in Patients with Advanced Gastric Cancer: A Randomised Phase III Noninferiority Trial. Annals of Oncology, 20, 666-673. https://doi.org/10.1093/annonc/mdn717
Wilke, H., Preusser, P., Fink, U., Gunzer, U., Meyer, H.J., Meyer, J., Siewert, J.R., Achterrath, W., Lenaz, L., Knipp, H., et al. (1989) Preoperative Chemotherapy in Locally Advanced and Nonresectable Gastric Cancer: A Phase II Study with Etoposide, Doxorubicin, and Cisplatin. Journal of Clinical Oncology, 7, 1318-1326. https://doi.org/10.1200/JCO.1989.7.9.1318
Chun, E.J. (2017) Ultrasonographic Evaluation of Complications Related to Transfemoral Arterial Procedures. Ultrasonography. https://doi.org/10.14366/usg.17047
Ibrahim, K., Christoph, M., Wunderlich, C., Jellinghaus, S., Loehn, T., Youssef, A., Schoener, L., Quick, S., Mierke, J., Strasser, R.H. and Pfluecke, C. (2017) A Novel Interventional Method for Treating Femoral Pseudoaneurysms: Results from a Monocentric Experience. Eurointervention, 13, 366-370. https://doi.org/10.4244/EIJ-D-16-00865
El-Mawardy, M., Schwarz, B., Landt, M., Sulimov, D., Kebernik, J., Allali, A., Becker, B., Toelg, R., Richardt, G. and Abdel-Wahab, M. (2017) Impact of Femoral Artery Puncture using Digital Subtraction Angiography and Road Mapping on Vascular and Bleeding Complications after Transfemoral Transcatheter Aortic Valve Implantation. Eurointervention, 12, 1667-1673. https://doi.org/10.4244/EIJ-D-15-00412
Panfilov, D.S., Kozlov, B.N., Panfilov, S.D., Kuznetsov, M.S., Nasrashvili, G.G. and Shipulin, V.M. (2016) Puncture Treatment of Pseudoaneurysms of Femoral Arteries with the Use of Human Thrombin. Angiologiya i Sosudistaya Khirurgiya, 22, 62-67.
Morzycki, A., Bhatia, A. and Murphy, K.J. (2017) Adverse Reactions to Contrast Material: A Canadian Update. Canadian Association of Radiologists Journal, 68, 187-193. https://doi.org/10.1016/j.carj.2016.05.006
Caschera, L., Lazzara, A., Piergallini, L., Ricci, D., Tuscano, B. and Vanzulli, A. (2016) Contrast Agents in Diagnostic Imaging: Present and Future. Pharmacological Research, 110, 65-75. https://doi.org/10.1016/j.phrs.2016.04.023
Sikka, A., Bisla, J.K., Rajan, P.V., Chalifoux, L.A., Goodhartz, L.A., Miller, F.H., Yaghmai, V. and Horowitz, J.M. (2016) How to Manage Allergic Reactions to Contrast Agent in Pregnant Patients. American Journal of Roentgenology, 206, 247-252. https://doi.org/10.2214/AJR.15.14976
Beckett, K.R., Moriarity, A.K. and Langer, J.M. (2015) Safe Use of Contrast Media: What the Radiologist Needs to Know. Radiographics, 35, 1738-1750. https://doi.org/10.1148/rg.2015150033
Li, H.Y., Guo, Y.T., Tian, C., Song, C.Q., Mu, Y., Li, Y. and Chen, Y.D. (2017) A Risk Prediction Score Model for Predicting Occurrence of Post-PCI Vasovagal Reflex Syndrome: A Single Center Study in Chinese Population. Journal of Geriatric Cardiology, 14, 509-514.
Frei, E.R. (1982) Multidisciplinary Treatment for Cancer—New Opportunities. International Journal of Radiation Oncology, Biology, Physics, 8, 951-952. https://doi.org/10.1016/0360-3016(82)90108-0
Imano, M., Itoh, T., Satou, T., Sogo, Y., Hirai, H., Kato, H., Yasuda, A., Peng, Y.F., Shinkai, M., Yasuda, T., Imamoto, H., Okuno, K., Shiozaki, H. and Ohyanagi, H. (2010) Prospective Randomized Trial of Short-Term Neoadjuvant Chemotherapy for Advanced Gastric Cancer. European Journal of Surgical Oncology, 36, 963-968. https://doi.org/10.1016/j.ejso.2010.06.012
Li, G.L., Fan, C.G., Bao, Y., Jiang, J., Li, N. and Li, J.S. (2009) Neoadjuvant Chemotherapy of FLEEOX Regimen for Unresectable Gastric Cancer Resulting from Advanced Abdominal Lymph Nodes Metastases. Chinese Journal of Surgery, 47, 1171-1174.
Dong, X.C., Li, B. and Li, Y.P. (2002) Effect of Preoperative Intra-Arterial Chemotherapy on Apoptosis and p53 Expression of Gastric Cancer. Chinese Journal of Cancer, 21, 1078-1080.
Tao, H.Q. and Zou, S.C. (2002) Effect of Preoperative Regional Artery Chemotherapy on Proliferation and Apoptosis of Gastric Carcinoma Cells. World Journal of Gastroenterology, 8, 451-454. https://doi.org/10.3748/wjg.v8.i3.451
Zhang, C., Li, G., Fan, C., Xu, J., Cao, J., Liu, S. and Li, N. (2012) Comparison of Efficacy of Different Route of Administration of Chemotherapy on Unresectable, Advanced Gastric Cancer. World Journal of Surgical Oncology, 10, 162. https://doi.org/10.1186/1477-7819-10-162
He, Q., Ma, L., Li, Y. and Li, G. (2016) A Pilot Study of an Individualized Comprehensive Treatment for Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis. BMC Gastroenterology, 16, 8. https://doi.org/10.1186/s12876-016-0422-7
Schuhmacher, C., Gretschel, S., Lordick, F., Reichardt, P., Hohenberger, W., Eisenberger, C.F., Haag, C., Mauer, M.E., Hasan, B., Welch, J., Ott, K., Hoelscher, A., Schneider, P.M., Bechstein, W., Wilke, H., Lutz, M.P., Nordlinger, B., Van Cutsem, E., Siewert, J.R. and Schlag, P.M. (2010) Neoadjuvant Chemotherapy Compared with Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954. Journal of Clinical Oncology, 28, 5210-5218. https://doi.org/10.1200/JCO.2009.26.6114
Basi, A., Sohrabkhani, S., Zamani, F., Baghai-Wadji, M., Rabiei, N., Razavi, S.M. and Ajdarkosh, H. (2013) Comparing Efficacy of Preoperative Neo-Adjuvant Chemotherapy and Surgery versus Surgery Alone in Patients with Resectable Gastroesophageal Cancer. International Journal of Hematology-Oncology and Stem Cell Research, 7, 24-28.
Songun, I., Keizer, H.J., Hermans, J., Klementschitsch, P., de Vries, J.E., Wils, J.A., van der Bijl, J., van Krieken, J.H. and van de Velde, C.J. (1999) Chemotherapy for Operable Gastric Cancer: Results of the Dutch Randomised FAMTX Trial. The Dutch Gastric Cancer Group (DGCG). European Journal of Cancer, 35, 558-562. https://doi.org/10.1016/S0959-8049(98)00429-8
You, X., Qian, H., Qin, L., Wang, Y., Li, W., Lian, Y., Zhao, X., Xu, N., Huang, C., Chen, Z. and Liu, G. (2016) Application Study on Regional Infusion Chemotherapy by Celiac Trunk during Operation in Advanced Gastric Cancer Patients. Chinese Journal of Gastrointestinal Surgery, 19, 1044-1048.
Wu, Y., Wei, Z.W., He, Y.L., Schwarz, R.E., Smith, D.D., Xia, G.K. and Zhang, C.H. (2013) Efficacy of Adjuvant XELOX and FOLFOX6 Chemotherapy after D2 Dissection for Gastric Cancer. World Journal of Gastroenterology, 19, 3309-3315. https://doi.org/10.3748/wjg.v19.i21.3309
Wu, Z., Ma, S., Jing, S., Deng, Q., Zheng, Z., Wu, K., Li, J., Chen, S., Tang, R. and Li, X. (2014) Effect of Hyperthermic Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy as Postoperative Adjuvant Therapy for Advanced Gastric Cancer. Hepatogastroenterology, 61, 972-977.
Wang, Y.Y., Zhang, W., Qian, S., Liu, R., Kan, Z.X. and Wang, J.H. (2012) The Effect of Locoregional Transarterial Infusion Chemotherapy on Liver Metastasis after Gastric Cancer Resection. Journal of International Medical Research, 40, 1141-1148. https://doi.org/10.1177/147323001204000334
Yang, K., Zhang, X.M., Yang, L., Xu, H. and Peng, J. (2016) Advanced Imaging Techniques in the Therapeutic Response of Transarterial Chemoembolization for Hepatocellular Carcinoma. World Journal of Gastroenterology, 22, 4835-4847. https://doi.org/10.3748/wjg.v22.i20.4835
Yang, L., Zhang, X.M., Tan, B.X., Liu, M., Dong, G.L. and Zhai, Z.H. (2012) Computed Tomographic Perfusion Imaging for the Therapeutic Response of Chemoembolization for Hepatocellular Carcinoma. Journal of Computer Assisted Tomography, 36, 226-230. https://doi.org/10.1097/RCT.0b013e318245c23c
Yang, L., Zhang, X.M., Zhou, X.P., Tang, W., Guan, Y.S., Zhai, Z.H. and Dong, G.L. (2010) Correlation between Tumor Perfusion and Lipiodol Deposition in Hepatocellular Carcinoma after Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology, 21, 1841-1846. https://doi.org/10.1016/j.jvir.2010.08.015
Hoink, A.J., Schulke, C., Koch, R., Lohnert, A., Kammerer, S., Fortkamp, R., Heindel, W. and Buerke, B. (2017) Response Evaluation of Malignant Liver Lesions after TACE/SIRT: Comparison of Manual and Semi-Automatic Measurement of Different Response Criteria in Multislice CT. Rofo, 189, 1067-1075. https://doi.org/10.1055/s-0043-116220
Ludwig, J.M., Camacho, J.C., Kokabi, N., Xing, M. and Kim, H.S. (2015) The Role of Diffusion-Weighted Imaging (DWI) in Locoregional Therapy Outcome Prediction and Response Assessment for Hepatocellular Carcinoma (HCC): The New Era of Functional Imaging Biomarkers. Diagnostics (Basel), 5, 546-563. https://doi.org/10.3390/diagnostics5040546
Hussain, H.K., Barr, D.C. and Wald, C. (2014) Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma and the Evaluation of Response to Treatment. Seminars in Liver Disease, 34, 398-414. https://doi.org/10.1055/s-0034-1394140
Yuan, Z., Li, W.T., Ye, X.D., Zhu, H.Y. and Peng, W.J. (2014) Novel Functional Magnetic Resonance Imaging Biomarkers for Assessing Response to Therapy in Hepatocellular Carcinoma. Clinical and Translational Oncology, 16, 599-605. https://doi.org/10.1007/s12094-013-1147-5
Jiang, T., Zhu, A.X. and Sahani, D.V. (2013) Established and Novel Imaging Biomarkers for Assessing Response to Therapy in Hepatocellular Carcinoma. Journal of Hepatology, 58, 169-177. https://doi.org/10.1016/j.jhep.2012.08.022
De Raffele, E., Mirarchi, M., Cuicchi, D., Lecce, F. and Cola, B. (2017) Evolving Role of FDG-PET/CT in Prognostic Evaluation of Resectable Gastric Cancer. World Journal of Gastroenterology, 23, 6923-6926. https://doi.org/10.3748/wjg.v23.i38.6923
Cheng, J., Wang, Y., Zhang, C.F., Wang, H., Wu, W.Z., Pan, F., Hong, N. and Deng, J. (2017) Chemotherapy Response Evaluation in a Mouse Model of Gastric Cancer using Intravoxel Incoherent Motion Diffusion-Weighted MRI and Histopathology. World Journal of Gastroenterology, 23, 1990-2001. https://doi.org/10.3748/wjg.v23.i11.1990
Yuan, J., Lo, G. and King, A.D. (2016) Functional Magnetic Resonance Imaging Techniques and Their Development for Radiation Therapy Planning and Monitoring in the Head and Neck Cancers. Quantitative Imaging in Medicine and Surgery, 6, 430-448. https://doi.org/10.21037/qims.2016.06.11
Bozgeyik, Z., Onur, M.R. and Poyraz, A.K. (2013) The Role of Diffusion Weighted Magnetic Resonance Imaging in Oncologic Settings. Quantitative Imaging in Medicine and Surgery, 3, 269-278.
He, Q., Li, G., Ji, X., Ma, L., Wang, X., Li, Y. and Fan, C. (2017) Impact of the Immune Cell Population in Peripheral Blood on Response and Survival in Patients Receiving Neoadjuvant Chemotherapy for Advanced Gastric Cancer. Tumor Biology, 39, 1-8. https://doi.org/10.1177/1010428317697571
Tahara, T., Shibata, T., Okubo, M., Kawamura, T., Horiguchi, N., Yoshida, D., Ishizuka, T., Nagasaka, M., Nakagawa, Y. and Ohmiya, N. (2017) Evaluations of Primary Lesions by Endoscopy Clearly Distinguishes Prognosis in Patients with Gastric Cancer Who Receive Chemotherapy. PLoS ONE, 12, e173663. https://doi.org/10.1371/journal.pone.0173663
Kim, J.S., Kang, S.H., Moon, H.S., Sung, J.K., Jeong, H.Y. and Sul, J.Y. (2016) Clinical Outcome of Doublet and Triplet Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. The Korean Journal of Gastroenterology, 68, 245-252. https://doi.org/10.4166/kjg.2016.68.5.245
Qu, J. and Qu, X. (2016) The Predictors of Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Gastric Cancer. Cancer Biomarkers, 17, 49-54. https://doi.org/10.3233/CBM-160616
Liu, K., Min, X.L., Peng, J., Yang, K., Yang, L. and Zhang, X.M. (2016) The Changes of HIF-1alpha and VEGF Expression after TACE in Patients with Hepatocellular Carcinoma. Journal of Clinical Medicine Research, 8, 297-302. https://doi.org/10.14740/jocmr2496w
Mamdouh, S., Khorshed, F., Aboushousha, T., Hamdy, H., Diab, A., Seleem, M. and Saber, M. (2017) Evaluation of Mir-224, Mir-215 and Mir-143 as Serum Biomarkers for HCV Associated Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention, 18, 3167-3171.
Fornaro, L., Vivaldi, C., Lin, D., Xue, H., Falcone, A., Wang, Y., Crea, F. and Bootman, M.D. (2017) Prognostic Relevance of a T-Type Calcium Channels Gene Signature in Solid Tumours: A Correlation Ready for Clinical Validation. PLoS ONE, 12, e182818. https://doi.org/10.1371/journal.pone.0182818
Mahfouz, N., Tahtouh, R., Alaaeddine, N., El, H.J., Sarkis, R., Hachem, R., Raad, I. and Hilal, G. (2017) Gastrointestinal Cancer Cells Treatment with Bevacizumab Activates a VEGF Autoregulatory Mechanism Involving Telomerase Catalytic Subunit hTERT via PI3K-AKT, HIF-1alpha and VEGF Receptors. PLoS ONE, 12, e179202. https://doi.org/10.1371/journal.pone.0179202
Liu, K., Yang, L., Zhang, X.M., Zhou, Y., Zhu, T., Miao, N.D., Ren, Y.J., Xu, H., Min, X.L., Peng, J., Yang, K. and Yang, S. (2017) HIF-1α and VEGF Levels for Monitoring Hepatocellular Carcinoma Treatment Response to Transcatheter Arterial Chemoembolization. Translational Cancer Research, 6, 1043-1049. https://doi.org/10.21037/tcr.2017.08.32
Min, X.L., Yang, L., Zhang, X.M., Zhou, Y., Miao, N.D., Ren, Y.J., Xu, H., Liu, K., Peng, J. and Yang, K. (2017) Changes of Tryptase in Patients with Hepatocellular Carcinoma after Transarterial Chemoembolization. Translational Cancer Research, 6, 1061-1067. https://doi.org/10.21037/tcr.2017.08.43